9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene

C146H84N12 — CID 158818178

IUPAC9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene
SMILESc1ccc(-c2nnc(-n3c4ccccc4c4c5c6ccc7ccccc7c6n6c7ccccc7c(cc43)c56)c3ccccc23)cc1.c1ccc2c(-c3nc4ccccc4nc3-c3ccc(-n4c5ccccc5c5c6c7ccc8ccccc8c7n7c8ccccc8c(cc54)c67)cc3)cccc2c1.c1ccc2cc(-c3nc4ccccc4nc3-c3ccc(-n4c5ccccc5c5c6c7ccc8ccccc8c7n7c8ccccc8c(cc54)c67)cc3)ccc2c1
InChIInChI=1S/2C52H30N4.C42H24N4/c1-3-15-35-31(12-1)14-11-19-38(35)50-49(53-42-20-7-8-21-43(42)54-50)33-24-27-34(28-25-33)55-45-23-10-6-18-39(45)47-46(55)30-41-37-17-5-9-22-44(37)56-51-36-16-4-2-13-32(36)26-29-40(51)48(47)52(41)56;1-2-13-34-29-35(22-21-31(34)11-1)50-49(53-42-17-7-8-18-43(42)54-50)33-23-26-36(27-24-33)55-45-20-10-6-16-39(45)47-46(55)30-41-38-15-5-9-19-44(38)56-51-37-14-4-3-12-32(37)25-28-40(51)48(47)52(41)56;1-2-13-26(14-3-1)39-29-17-6-7-18-30(29)42(44-43-39)45-35-21-11-9-19-31(35)37-36(45)24-33-28-16-8-10-20-34(28)46-40-27-15-5-4-12-25(27)22-23-32(40)38(37)41(33)46/h2*1-30H;1-24H
InChIKeyIVNOMUHJPJKZQS-UHFFFAOYSA-N
MW2006.36 g/mol
LogP37.73
Rot. Bonds8

About 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene

9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene (PubChem CID 158818178) has the molecular formula C146H84N12 and a molecular weight of 2006.36 g/mol. Its IUPAC name is 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene.

Molecular Properties

Compound Name9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene
PubChem CID158818178
Molecular FormulaC146H84N12
Molecular Weight2006.36 g/mol
Exact Mass2004.69
IUPAC Name9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene
SMILESc1ccc(-c2nnc(-n3c4ccccc4c4c5c6ccc7ccccc7c6n6c7ccccc7c(cc43)c56)c3ccccc23)cc1.c1ccc2c(-c3nc4ccccc4nc3-c3ccc(-n4c5ccccc5c5c6c7ccc8ccccc8c7n7c8ccccc8c(cc54)c67)cc3)cccc2c1.c1ccc2cc(-c3nc4ccccc4nc3-c3ccc(-n4c5ccccc5c5c6c7ccc8ccccc8c7n7c8ccccc8c(cc54)c67)cc3)ccc2c1
InChIInChI=1S/2C52H30N4.C42H24N4/c1-3-15-35-31(12-1)14-11-19-38(35)50-49(53-42-20-7-8-21-43(42)54-50)33-24-27-34(28-25-33)55-45-23-10-6-18-39(45)47-46(55)30-41-37-17-5-9-22-44(37)56-51-36-16-4-2-13-32(36)26-29-40(51)48(47)52(41)56;1-2-13-34-29-35(22-21-31(34)11-1)50-49(53-42-17-7-8-18-43(42)54-50)33-23-26-36(27-24-33)55-45-20-10-6-16-39(45)47-46(55)30-41-38-15-5-9-19-44(38)56-51-37-14-4-3-12-32(37)25-28-40(51)48(47)52(41)56;1-2-13-26(14-3-1)39-29-17-6-7-18-30(29)42(44-43-39)45-35-21-11-9-19-31(35)37-36(45)24-33-28-16-8-10-20-34(28)46-40-27-15-5-4-12-25(27)22-23-32(40)38(37)41(33)46/h2*1-30H;1-24H
InChIKeyIVNOMUHJPJKZQS-UHFFFAOYSA-N
XLogP37.73
TPSA105.36 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds8
Heavy Atoms158
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002006.36
LogP ≤ 537.73
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Analyze 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene?
The IUPAC name of 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene (CID 158818178) is 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene.
What is the SMILES notation for 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene?
The canonical SMILES for 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene is c1ccc(-c2nnc(-n3c4ccccc4c4c5c6ccc7ccccc7c6n6c7ccccc7c(cc43)c56)c3ccccc23)cc1.c1ccc2c(-c3nc4ccccc4nc3-c3ccc(-n4c5ccccc5c5c6c7ccc8ccccc8c7n7c8ccccc8c(cc54)c67)cc3)cccc2c1.c1ccc2cc(-c3nc4ccccc4nc3-c3ccc(-n4c5ccccc5c5c6c7ccc8ccccc8c7n7c8ccccc8c(cc54)c67)cc3)ccc2c1.
What is the InChIKey of 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene?
The InChIKey is IVNOMUHJPJKZQS-UHFFFAOYSA-N. The full InChI is InChI=1S/2C52H30N4.C42H24N4/c1-3-15-35-31(12-1)14-11-19-38(35)50-49(53-42-20-7-8-21-43(42)54-50)33-24-27-34(28-25-33)55-45-23-10-6-18-39(45)47-46(55)30-41-37-17-5-9-22-44(37)56-51-36-16-4-2-13-32(36)26-29-40(51)48(47)52(41)56;1-2-13-34-29-35(22-21-31(34)11-1)50-49(53-42-17-7-8-18-43(42)54-50)33-23-26-36(27-24-33)55-45-20-10-6-16-39(45)47-46(55)30-41-38-15-5-9-19-44(38)56-51-37-14-4-3-12-32(37)25-28-40(51)48(47)52(41)56;1-2-13-26(14-3-1)39-29-17-6-7-18-30(29)42(44-43-39)45-35-21-11-9-19-31(35)37-36(45)24-33-28-16-8-10-20-34(28)46-40-27-15-5-4-12-25(27)22-23-32(40)38(37)41(33)46/h2*1-30H;1-24H.
What are the key properties of 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene?
9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene has a molecular weight of 2006.36 g/mol, XLogP of 37.73, 8 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 9-[4-(3-naphthalen-1-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-[4-(3-naphthalen-2-ylquinoxalin-2-yl)phenyl]-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene;9-(4-phenylphthalazin-1-yl)-9,19-diazaoctacyclo[17.10.1.02,10.03,8.012,30.013,18.020,29.021,26]triaconta-1(30),2(10),3,5,7,11,13,15,17,20(29),21,23,25,27-tetradecaene is sourced from PubChem (CID 158818178), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).